S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LGND Ligand Pharmaceuticals Incorporated

120.74

-2.73 (-2.21%)

After Hours

Last Updated: 08:00:25

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals Incorporated News

Form 144 - Report of proposed sale of securities
Wednesday 13 November 2024 (7 hours ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 9 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 9 November 2024 (4 days ago) • Edgar (US Regulatory)

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Thursday 17 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 24 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 24 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 31 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 31 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 29 August 2024 (2 months ago) • Edgar (US Regulatory)

More Ligand Pharmaceuticals Incorporated News Articles

Ligand Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions